On January 26, 2018, the U.S. Food and Drug Administration (FDA) approved lutetium Lu 177 dotatate a radiolabeled somatostatin analog, for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut, and hindgut neuroendocrine tumors in adults.
The American Cancer Society has partnered with the Centers for Disease Control and Prevention (CDC) to promote public awareness and adoption for the human papilloma virus (HPV) vaccine. The joint initiative, dubbed the National HPV Vaccination Roundtable, brings together public, private, and voluntary experts to raise awareness of the benefits of the vaccine in an effort to decrease incidence and mortality rates associated with HPV cancers.
The National Academies of Sciences, Engineering, and Medicine recently released its latest report on the consequences of smoking, specifically related to electronic cigarettes. The report discusses the new effects of e-cigarettes as a public health hazard. According to the report, the effects of long-term e-cigarette use are still unknown, especially related to morbidity and mortality.
American author Kurt Vonnegut once wrote, “Laughter and tears are both responses to frustration and exhaustion. . . . I myself prefer to laugh, since there is less cleaning up to do afterward.” Humor has the ability to sooth and heal, and humor often makes grim situations feel brighter and less daunting. Moments affixed with tragedy, grief, loss, and terror can often soften in time, allowing for understanding, acceptance, and sometimes even laughter.
Researchers have generated immunotherapy in the laboratory using nonimmune cells. If the findings can be translated into treatment, it may reduce some of the immune-related adverse events that patients experience with today’s cancer immunotherapy treatments. The study was reported in Nature Chemical Biology.
Family members are often the first people to step into the caregiver role when a loved one gets sick. However, studies show that caregivers face unintended burdens and potential consequence as a result of the support and care they give to loved ones.
Do you promote optimal patient outcomes, advocate for patients’ voices, and implement change? Then you’re a nurse leader. It is easy to think of nurse leaders as those in administrative positions or conducting bedside research, but the reality is that nursing leadership can take on many roles through a variety of different nursing positions, from generalist to certified to advanced practice. Leadership is about influencing change and improvement, inspiring those around you.
ONS member Ruth McCorkle, PhD, RN, FAAN, was awarded the Yale Comprehensive Cancer Center’s Lifetime Achievement Award for her national and international contributions to oncology, specifically in the areas of palliative care, psychosocial care, and quality of life research. McCorkle is the first nurse to receive this honor from the Yale Cancer Center.
Former ONS member Margo McCaffery, RN, MS, FAAN, was a leader and pioneer in pain management for nursing. Through her work, she helped to identify and treat patients with acute and chronic pain in a number of healthcare settings. McCaffery’s 1968 definition of pain was simple—“It’s whatever the experiencing person says it is, existing whenever and wherever the person says it does.” Her words have become a touchstone for clinicians addressing and treating patients in pain.
Addressing a clinical problem through evidence-based practice (EBP) involves asking the right questions in the right way, finding the best available evidence, and assessing what practice change may be needed. A core factor in the EBP journey is the development of nurses who possess a spirit of inquiry within a culture that supports a systematic process for asking clinical questions.